US Patent 11208482 Humanized antibodies against c-Kit
Patent 11208482 was granted and assigned to Forty Seven on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+165 characters)
Article
Patent abstract
The invention provides antibodies specifically binding to c-Kit and methods of using such antibodies in stem cell replacement and treatment of cancer.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
112084820
Date of Patent
December 28, 2021
0Patent Application Number
166949750
Date Filed
November 25, 2019
0Official Website
Patent Primary Examiner
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
Patent Jurisdiction
Patent Number
112084820
Date of Patent
December 28, 2021
0Patent Application Number
166949750
Date Filed
November 25, 2019
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11208482 Humanized antibodies against c-Kit
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11208482
Date of patent
December 28, 2021
Patent application number
16694975
Date Filed
November 25, 2019
Patent primary examiner
Find more entities like US Patent 11208482 Humanized antibodies against c-Kit
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.